Literature DB >> 11701268

Extremely low-dose ACTH therapy for West syndrome in Japan.

M Ito1.   

Abstract

Adrenocorticotropic hormone (ACTH) therapy is a widely used and effective treatment for West syndrome. However, serious adverse effects can occur during or shortly after ACTH therapy. Synthetic ACTH has been reported to cause more adverse effects than natural ACTH. Currently, most Japanese pediatric neurologists try other non-hormonal treatments before using ACTH therapy, but even then, they use extremely low dosages of synthetic ACTH. The extremely low-dose synthetic ACTH therapy currently used in Japan is as effective for treatment of West syndrome as the higher doses reported in previous studies from Japan and Western countries. The dosage and duration of synthetic ACTH therapy should be as low as possible to avoid serious adverse effects. Close monitoring of the adverse effects, especially subdural hematoma, is necessary even when extremely low dosages of ACTH are administered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701268     DOI: 10.1016/s0387-7604(01)00302-3

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

Review 1.  Infantile spasms: review of the literature and personal experience.

Authors:  Alberto Fois
Journal:  Ital J Pediatr       Date:  2010-02-08       Impact factor: 2.638

Review 2.  Corticosteroids in the management of the paediatric epilepsies.

Authors:  R Gupta; R Appleton
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

3.  Hyperactive mTOR signals in the proopiomelanocortin-expressing hippocampal neurons cause age-dependent epilepsy and premature death in mice.

Authors:  Yuki Matsushita; Yasunari Sakai; Mitsunori Shimmura; Hiroshi Shigeto; Miki Nishio; Satoshi Akamine; Masafumi Sanefuji; Yoshito Ishizaki; Hiroyuki Torisu; Yusaku Nakabeppu; Akira Suzuki; Hidetoshi Takada; Toshiro Hara
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

4.  What Matters the Most for Hormonal Therapy in West Syndrome: Drug, Dosage, or Duration?

Authors:  Jitendra Kumar Sahu; Priyanka Madaan
Journal:  Indian J Pediatr       Date:  2021-03-27       Impact factor: 1.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.